ACFNACFNNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank51
5Y CAGR-16.8%
Year-over-Year Change
Year-over-year research & development expense growth
5Y CAGR
-16.8%/yr
Long-term compound
Percentile
P51
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 1.50% |
| Q3 2025 | 0.75% |
| Q2 2025 | -8.93% |
| Q1 2025 | -7.32% |
| Q4 2024 | 34.19% |
| Q3 2024 | 3.54% |
| Q2 2024 | -5.04% |
| Q1 2024 | -8.81% |
| Q4 2023 | 23.11% |
| Q3 2023 | 12.77% |
| Q2 2023 | -12.15% |
| Q1 2023 | 2.88% |
| Q4 2022 | -8.37% |
| Q3 2022 | 7.08% |
| Q2 2022 | 7.07% |
| Q1 2022 | -4.35% |
| Q4 2021 | 15.64% |
| Q3 2021 | 2.29% |
| Q2 2021 | -1.69% |
| Q1 2021 | 7.23% |
| Q4 2020 | 3.75% |
| Q3 2020 | 15.94% |
| Q2 2020 | -10.97% |
| Q1 2020 | 11.51% |
| Q4 2019 | 1.46% |
| Q3 2019 | -1.44% |
| Q2 2019 | -3.47% |
| Q1 2019 | 0.70% |
| Q4 2018 | 2.88% |
| Q3 2018 | 6.11% |
| Q2 2018 | 1.55% |
| Q1 2018 | 0.78% |
| Q4 2017 | 4.92% |
| Q3 2017 | -30.68% |
| Q2 2017 | 91.30% |
| Q1 2017 | -32.35% |
| Q4 2016 | 2.26% |
| Q3 2016 | -54.61% |
| Q2 2016 | -19.73% |
| Q1 2016 | -35.96% |